Minimum Dose CT Post Lung Biopsy

This study has been completed.
Information provided by:
University Health Network, Toronto Identifier:
First received: September 12, 2005
Last updated: April 20, 2007
Last verified: September 2005

The aim is to evaluate whether Minimum Dose CT (MnDCT) is useful in the management of patients post Lung Biopsy

Condition Intervention Phase
Lung Cancer
Device: CT
Phase 1

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Diagnostic
Official Title: Can Minimum Dose CT Post Lung Biopsy Predict Patient Outcome?

Resource links provided by NLM:

Further study details as provided by University Health Network, Toronto:

Primary Outcome Measures:
  • Detection of Pneumothorax

Estimated Enrollment: 100
Study Start Date: January 2004
Study Completion Date: September 2005
Detailed Description:

Patients post Lung Biopsy have a chest X-ray (CXR) and a MnDCT post lung biopsy. Both studies are compared for the detection of a pneumothorax


Ages Eligible for Study:   16 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • All Patients having a lung biopsy

Exclusion Criteria:

  • None
  Contacts and Locations
Please refer to this study by its identifier: NCT00188162

Canada, Ontario
Toronto General Hospital
Toronto, Ontario, Canada
Sponsors and Collaborators
University Health Network, Toronto
Principal Investigator: Narinder Paul, FRCP C University Health Network, Toronto
  More Information

No publications provided Identifier: NCT00188162     History of Changes
Other Study ID Numbers: 03-0898
Study First Received: September 12, 2005
Last Updated: April 20, 2007
Health Authority: Canada: Health Canada

Additional relevant MeSH terms:
Lung Neoplasms
Respiratory Tract Neoplasms
Thoracic Neoplasms
Neoplasms by Site
Lung Diseases
Respiratory Tract Diseases processed this record on April 23, 2014